Lack of impact of YMDD mutants on efficacy or safety of two years therapy with adefovir dipivoxil (ADV) in Chinese HBeAg positive chronic hepatitis B (CHB) patients

被引：0
|
作者：
Mao, Yi-Min
Zeng, Min-De
Zhou, Xia-Qiu
Wang, Hao
Ren, Hong
Niu, Jun-Qi
Dixon, Jonathan S.
Barker, Keith F.
机构：
[1] Renji Hosp, Shanghai, Peoples R China
[2] Ruijin Hosp, Shanghai, Peoples R China
[3] Beijing Peoples Hosp, Beijing, Peoples R China
[4] CMU 2nd Hosp, Chongqing, Peoples R China
[5] Jilin Univ, Hosp 1, Changchun 130023, Peoples R China
[6] GlaxoSmithKline R&D, Brentford, England
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A106 / A106
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of two years therapy with adefovir dipivoxil (ADV) in Chinese patients with HBeAg positive chronic hepatitis B (CHB)
    Mao, Yiming
    Zeng, Minde
    Yao, Guangbi
    Xu, Daozhen
    Hou, Jinlin
    Chen, Yagang
    Dixon, Jon S.
    Barker, Keith F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A14 - A15
  • [2] Safety of two years therapy with adefovir dipivoxil (ADV) for Chinese patients with HBeAg positive chronic hepatitis B (CHB)
    Zeng, Min-De
    Mao, Yi-Min
    Lu, Wei-Lun
    Wang, Yu-Ming
    Wang, Yao-Zong
    Dixon, Jonathan S.
    Barker, Keith F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A105 - A106
  • [3] Efficacy of two years therapy with adefovir dipivoxil (ADV) in Chinese patients with HBeAg positive chronic hepatitis B (CHB)
    Zeng, Min-De
    Mao, Yi-Min
    Yao, Guang-Bi
    Xu, Dao-Zhen
    Hou, Jin-Lin
    Chen, Ya-Gang
    Dixon, Jonathan S.
    Barker, Keith F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A71 - A72
  • [4] Efficacy and safety of 2 years adefovir dipivoxil (ADV) in Chinese patients with HBeAg positive chronic hepatitis B (CHB)
    Zeng, M. D.
    Mao, Y. M.
    Yao, G. B.
    Wang, H.
    Hou, J. L.
    Wang, Y. Z.
    Dixon, J. S.
    Barker, K. F.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S185 - S185
  • [5] Efficacy, safety and low resistance of three years therapy with adefovir dipivoxil (ADV) in Chinese patients with HBeAg positive chronic hepatitis B (CHB)
    Mao, Yimin
    Zeng, Minde
    Yao, Guangbi
    Gao, Zhiliang
    Hou, Jinlin
    Wang, Hao
    Barker, Keith F.
    Dixon, Jon S.
    HEPATOLOGY, 2006, 44 (04) : 699A - 699A
  • [6] Adefovir dipivoxil (ADV) demonstrates sustained efficacy in HBeAg- chronic hepatitis B (CHB) patients
    Hadziyannis, S
    Tassopoulos, N
    Chang, TT
    Heathcote, J
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Arterburn, S
    Ma, J
    Xiong, S
    Brosgart, CL
    Currie, G
    JOURNAL OF HEPATOLOGY, 2005, 42 : 178 - 178
  • [7] Adefovir dipivoxil (ADV) demonstrates sustained efficacy in HBeAg- chronic hepatitis B (CHB) patients
    Hadziyannis, S
    Tassopoulos, N
    Chang, TT
    Heathcote, J
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Arterburn, S
    Ma, J
    Xiong, S
    Brosgart, CL
    Currie, G
    GASTROENTEROLOGY, 2005, 128 (04) : A693 - A693
  • [8] Resistance surveillance of HBeAg- chronic hepatitis B (CHB) patients treated for two years with adefovir dipivoxil (ADV)
    Xiong, S
    Yang, H
    Westland, CE
    Delaney, WE
    Colledge, D
    Bartholomeusz, A
    Thibault, V
    Benhamou, Y
    Angus, P
    Wulfsohn, M
    Gibbs, CS
    Fry, J
    Brosgart, CL
    Locarnini, S
    JOURNAL OF HEPATOLOGY, 2003, 38 : 182 - 182
  • [9] Resistance surveillance in HBeAg-chronic hepatitis B patients (CHB) patients treated with adefovir dipivoxil (ADV) for two years.
    Gibbs, CS
    Xiong, S
    Yang, H
    Westland, CE
    Delaney, WE
    Colledge, D
    Bartholomeusz, A
    Thibault, V
    Benhamou, Y
    Angus, P
    Wulfsohn, M
    Fry, J
    Brosgart, CL
    Locarnini, S
    ANTIVIRAL RESEARCH, 2003, 57 (03) : A43 - A43
  • [10] Long-term efficacy and safety of adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B (CHB) patients
    Marcellin, Patrick
    Chang, Ting-Tsung
    Lim, Seng Gee
    Sievert, William
    Tong, Myron
    Arterburn, Sarah
    Borroto-Esoda, Katyna
    Chuck, Steven
    HEPATOLOGY, 2006, 44 (04) : 548A - 548A
12345